Erlofast 150mg Tablet

By Erlofast

Rx

30 Tablet in a Bottle

Composition icon

Composition

Erlotinib(150mg)

Manufacturer - Celon Laboratories Ltd icon

Manufacturer - Celon Laboratories Ltd

Plot No 264, Patrika Nagar Madhapur, Hitech City Hyderabad, Telangana India - 500081

Expires on or after icon

Expires on or after

July, 2025

About Erlofast 150mg Tablet

Erlofast 150mg Tablet is a medication used to treat non-small cell lung cancer and pancreatic cancer. It is important to follow the dosing instructions carefully. The tablet should be taken on an empty stomach or at least one hour before or two hours after a meal. It is crucial to continue taking the medicine as long as your doctor advises, as the duration of treatment varies based on individual needs and response to the treatment.

Taking Erlofast 150mg Tablet correctly is essential to avoid serious side effects. Common side effects may include nausea, vomiting, fatigue, rash, and weight loss. If you experience severe diarrhea, it is recommended to drink plenty of fluids and consult your doctor. This medication can also make you more sensitive to sunlight, so wearing protective clothing and using sunscreen is advised. Inform your doctor if you have any oral ulceration, changes in vision, or breathing difficulties while taking Erlofast 150mg Tablet.

It is important to note that Erlofast 150mg Tablet may interact with other medications, so it is crucial to inform your healthcare team about all the medicines you are using. This medicine is not recommended during pregnancy or while breastfeeding. Both males and females should use effective contraception during treatment to prevent pregnancy. Additionally, quitting smoking is advised while taking this medicine, as smoking can impact its effectiveness.

Regular monitoring of liver function may be advised by your doctor while you are on this medication. If you need to take an antacid or any other medicine, ensure to take it at least 2 hours after taking the cancer medicine. Adhering to these guidelines and closely following your doctor's advice will help in the effective management of your condition with Erlofast 150mg Tablet.


Benefits

Erlofast 150mg Tablet offers significant benefits for individuals battling non-small cell lung cancer and pancreatic cancer. In the case of non-small cell lung cancer, a prevalent form of lung cancer affecting both smokers and non-smokers, this medication plays a crucial role in treatment. It can be used either on its own or in combination with other medications. Erlofast 150mg Tablet is a potent medicine with the ability to combat the progression of non-small cell lung cancer effectively. Patients are advised to have an open discussion with their healthcare provider to understand the associated risks and benefits. It is important to note that during the treatment with Erlofast 150mg Tablet, avoiding alcohol consumption is recommended, while ensuring adequate hydration by drinking plenty of water.

When it comes to pancreatic cancer, the pancreas plays a vital role in the digestion process and regulating blood sugar levels by producing natural insulin. Erlofast 150mg Tablet is a valuable resource in managing pancreatic cancer by addressing symptoms such as loss of appetite and unexplained weight loss. By inhibiting the actions of specific chemicals that promote the growth and spread of pancreatic cancer, this medication helps to control the disease and enhance the quality of life for patients. Ultimately, Erlofast 150mg Tablet offers individuals diagnosed with pancreatic cancer the potential to lead longer and healthier lives by effectively managing the disease progression.


How to use the Erlofast 150mg Tablet

To use Erlofast 150mg Tablet, follow the instructions given by your doctor regarding the dosage and duration of the medication. Swallow the tablet whole with a glass of water on an empty stomach. Do not chew, crush, or break the tablet before taking it. It is important to adhere to your doctor's guidance to ensure the effectiveness of the medication. Consult your healthcare provider if you have any doubts or concerns about how to properly use Erlofast 150mg Tablet.


Uses of Erlofast 150mg Tablet

Erlofast 150mg Tablet is commonly used in the treatment of non-small cell lung cancer and pancreatic cancer. This medication is prescribed by healthcare providers to help manage these types of cancers by targeting specific pathways in the body related to their growth and spread. Patients with non-small cell lung cancer or pancreatic cancer may benefit from Erlofast 150mg Tablet as part of their treatment plan to help slow down the progression of the disease and improve their overall quality of life.


What conditions Erlofast 150mg Tablet treats?

Erlofast 150mg Tablet is prescribed for non-small cell lung cancer and pancreatic cancer. For effective treatment, it should be taken on an empty stomach as advised by your doctor. Common side effects like nausea, vomiting, rash, and weight loss may occur. Be cautious of severe diarrhea and sensitivity to sunlight. Inform your doctor about any concerning symptoms. Regular liver function monitoring is recommended. Avoid alcohol and quit smoking during treatment. Effective contraception is important, and consult your healthcare team about other medications. If side effects persist, consult your doctor promptly.


Should you consult a doctor?

If you experience any concerning symptoms while taking Erlofast 150mg Tablet, it is important to seek medical attention promptly. Contact your doctor if you develop ulceration in the mouth, experience changes in vision, or have difficulty breathing. Additionally, it is essential to inform your healthcare provider if you notice persistent side effects such as severe diarrhea, which can be managed by increasing fluid intake or with medical guidance.

Regular monitoring of liver function may be recommended by your doctor while using this medication. If you encounter abdominal or bone pain, breathlessness, persistent cough, or unexplained fever, it is advisable to consult your healthcare team. Any signs of infection, muscle pain, or significant weight loss should also be reported for proper evaluation.

Remember to disclose all medications you are taking to avoid potential interactions. Erlofast 150mg Tablet is not recommended during pregnancy or breastfeeding, and the use of effective contraception is crucial. If you are a smoker, it is advised to quit while on this medication to optimize its effectiveness. If you need to take antacids or other medications, ensure a time gap of at least 2 hours after using the cancer medicine to prevent any interference.


Side effects of Erlofast 150mg Tablet

When taking Erlofast 150mg Tablet, some common side effects may occur. These side effects are typically mild and may go away as your body gets used to the medication. However, if any of these side effects persist or cause concern, it is important to consult your doctor for guidance. Possible side effects include abdominal pain, bone pain, breathlessness, constipation, cough, diarrhea, fatigue, fever, infection, muscle pain, nausea, rash, stomatitis (inflammation of the mouth), vomiting, and weight loss. Monitoring your symptoms and discussing any concerns with your healthcare provider can help ensure you have the support you need while taking this medication.


Safety advice

scroll

liver

When it comes to using Erlofast 150mg Tablet for patients with liver disease, caution is advised. It is important to consult with your doctor before starting treatment with this medication. Some patients with liver disease may require a dose adjustment when taking Erlofast 150mg Tablet. While limited information is available on the use of this tablet in patients with liver issues, it is noted that no dose adjustment is generally recommended for those with mild to moderate liver disease. Always seek guidance from your healthcare provider to ensure the safe and appropriate use of Erlofast 150mg Tablet.

scroll

kidney

Erlofast 150mg Tablet is safe for patients with kidney disease. No dose adjustment needed. Not recommended for those with severe kidney disease.

scroll

alcohol

Consult your doctor when consuming alcohol with Erlofast 150mg Tablet.

scroll

driving

It is not clear if Erlofast 150mg Tablet affects driving ability. Avoid driving if you notice any symptoms that impact focus or reaction time.

scroll

pregnancy

Erlofast 150mg Tablet is not safe to use during pregnancy due to the risk it poses to the developing baby. However, in rare life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before use.

scroll

breastfeeding

Erlofast 150mg Tablet may not be safe during breastfeeding, as there is a risk of the drug passing into breastmilk and potentially harming the baby. It is recommended to consult a doctor before using this medication while breastfeeding.


Consumption warning before consuming Erlofast 150mg Tablet

Before consuming Erlofast 150mg Tablet, it is crucial to follow certain precautions to ensure safe and effective treatment. Take this medication either on an empty stomach or at least one hour before or two hours after a meal as advised by your doctor. It is essential to adhere to your doctor's instructions strictly to avoid serious side effects that can result from incorrect usage or overdose. The duration of treatment may vary depending on your individual response, hence do not discontinue unless instructed by your doctor.

Common side effects of Erlofast 150mg Tablet include nausea, vomiting, fatigue, rash, and weight loss. Severe diarrhea may occur, in which case adequate fluid intake is recommended. Be cautious of increased sensitivity to sunlight, and protect yourself by wearing suitable clothing and using sunscreen. If you experience mouth ulcers, vision changes, or breathing difficulties while on this medication, inform your doctor promptly. Regular monitoring of liver function may be recommended during treatment.

Inform your healthcare provider about all medications you are taking, as interactions can occur. Avoid using Erlofast 150mg Tablet during pregnancy or breastfeeding, and reliable contraception is advised for both sexes to prevent pregnancy. Quit smoking while on this medication, as it may affect its efficacy. If taking an antacid or any other medication, ensure a time gap of at least 2 hours after consuming the cancer medicine.


What if you forgot to take Erlofast 150mg Tablet?

If you forget to take a dose of Erlofast 150mg Tablet, simply skip that dose and resume your regular dosing schedule. It is important not to take a double dose to make up for the missed one. Just continue with the next scheduled dose as prescribed by your healthcare provider. Taking a double dose can increase your risk of experiencing unwanted side effects, so it's best to stick to the recommended schedule. Remember to always follow your healthcare provider's instructions regarding the use of Erlofast 150mg Tablet to ensure you get the most benefit from this medication.


Related lab tests

For patients taking Erlofast 150mg Tablet, certain lab tests are important to monitor their health. One of the relevant lab tests is the Carcino Embryonic Antigen (CEA) test. The CEA test is used to measure the level of a protein called carcinoembryonic antigen in the blood. High levels of CEA can indicate the presence of certain types of cancer, including colorectal, pancreatic, and lung cancer. Monitoring CEA levels during treatment with Erlofast 150mg Tablet can help healthcare providers assess response to therapy and detect any potential cancer recurrence early. It is recommended to regularly undergo the CEA test as part of the comprehensive monitoring plan for patients using Erlofast 150mg Tablet. Additionally, other related lab tests that may be relevant for patients on this medication include liver function tests, complete blood count, and electrolyte levels. Regular monitoring through these lab tests can help ensure the effectiveness and safety of treatment with Erlofast 150mg Tablet.


Additional Information

Habit FormingNo
Chemical ClassQuinazoline Derivative
Therapeutic Class-
Action ClassTyrosine kinase inhibitors

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

7200

Inclusive of all taxes

Content verified by

chevron-right

Dr. Archana Prabhakar

MBBS, M.Med (Family Medicine)

Last update on 11-Feb-2025